4 Senior Executives Are Leaving Sanofi Following New CEO's Strategic OverhaulThe Motley Fool • 02/11/20
Sanofi's Acquisition Enhances Its Immuno-Oncology Pipeline With Potential Game-Changing ProductSeeking Alpha • 12/23/19